A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was criticized, a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical mainstream. Dr. Jerry Rosenbaum, director of the Psychedelics Neuroscience Center at Massachusetts General Hospital, joins NewsNation's "Morning in America" to discuss the drug's impact on the mind. #Psychedelics #MentalHealth #PTSD Start your day with "Morning in America," NewsNation's live three-hour national weekend morning newscast hosted by Hena Doba. Saturday and Sunday starting at 7a/6C. #MorningInAmerica NewsNation is your source for fact-based, unbiased news for all America. More from NewsNation: newsnationnow.com Get our app: trib.al/TBXgYpp Find us on cable: trib.al/YDOpGyG How to watch on TV or streaming: trib.al/Vu0Ikij